Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Ramachandran Kartik V. — Ernexa Therapeutics Inc. insider: 1 transactions · InsiderLens

/ / Ramachandran Kartik V.

Ramachandran Kartik V.

Chief Strat Off, EVP Bus Dev at Ernexa Therapeutics Inc. · on record since Apr 28, 2009

Insider trading activity of Ramachandran Kartik V.

Transactions on record: 1; since Apr 28, 2009

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 28, 2009

Figures computed from official regulatory filings — .

Companies where Ramachandran Kartik V. has traded

Ernexa Therapeutics Inc.1 tx · Apr 28, 2009

Track record of Ramachandran Kartik V.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Ramachandran Kartik V.

Co-insiders of Ramachandran Kartik V.

Angel MatthewErnexa Therapeutics Inc.
ARLEN GARY HErnexa Therapeutics Inc.
Arzt Michael AErnexa Therapeutics Inc.
AWM Investment Company, Inc.Ernexa Therapeutics Inc.
Bateman Terry AllanErnexa Therapeutics Inc.
BENNETT ROBERT MErnexa Therapeutics Inc.
Berger KendraErnexa Therapeutics Inc.
Berg Jeffrey AlanErnexa Therapeutics Inc.
BERGSMAN BARRYErnexa Therapeutics Inc.
BINDER BRANTErnexa Therapeutics Inc.
Boozer JohnErnexa Therapeutics Inc.
Bourbiel JenniferErnexa Therapeutics Inc.
Boylan Peter James IIIErnexa Therapeutics Inc.
Bristol James ArthurErnexa Therapeutics Inc.
Buckner Mark DErnexa Therapeutics Inc.
BUSH MICHAEL JErnexa Therapeutics Inc.
CARRINO VINCENTErnexa Therapeutics Inc.
Chandler BarryErnexa Therapeutics Inc.
Cherington CharlesErnexa Therapeutics Inc.
Cicala PeterErnexa Therapeutics Inc.
Clarke Dorothy JErnexa Therapeutics Inc.
CLASEN ROBERT BErnexa Therapeutics Inc.
COONEY ROBERT JErnexa Therapeutics Inc.
Danilovic MarianaErnexa Therapeutics Inc.
DE GORTER MARKErnexa Therapeutics Inc.
DENNY GEORGE P IIIErnexa Therapeutics Inc.
Duckett Peter A.Ernexa Therapeutics Inc.
ELLIN ROBERT SErnexa Therapeutics Inc.
Farricielli Joseph J. Jr.Ernexa Therapeutics Inc.
Fidelity National Financial, Inc.Ernexa Therapeutics Inc.
FIDELITY NATIONAL FINANCIAL INC /DE/Ernexa Therapeutics Inc.
FLEMING MICHAEL KErnexa Therapeutics Inc.

This page republishes public regulatory disclosures.

FRAKES JAMES BErnexa Therapeutics Inc.

Freebird Investments LLCErnexa Therapeutics Inc.

Freebird Partners LPErnexa Therapeutics Inc.

Gaffney JohnErnexa Therapeutics Inc.

George Christopher AllenErnexa Therapeutics Inc.

Glassman Nicholas AErnexa Therapeutics Inc.

Gottlieb MichaelErnexa Therapeutics Inc.

Gurrola Sandra MErnexa Therapeutics Inc.

HALPERN JOHN DErnexa Therapeutics Inc.

HUFF CURTIS WErnexa Therapeutics Inc.

Keymer Kenneth LErnexa Therapeutics Inc.

Khuchua VladimirErnexa Therapeutics Inc.

KINSEY STANLEY BErnexa Therapeutics Inc.

Krishnan RamErnexa Therapeutics Inc.

LAM VICTOR TYRONEErnexa Therapeutics Inc.

Lewis Mary BethErnexa Therapeutics Inc.

Luther SanjeevErnexa Therapeutics Inc.

Miller Dave BrianErnexa Therapeutics Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src	Details
Ernexa Therapeutics Inc.Listing on record	Apr 28, 2009	AwardD (derivative)	175,000	0.00	—	SEC